Table 2.
GH n=15 | PE n=143 | CH n=16 | HDP n=174 | Non-HDP n=92 | P value HDP vs non-HDP | |
Chronic hypertension | 0.53 | 0.78 | 0.81 | 0.76 | 0.62 | 0.02 |
Diabetes | 0.27 | 0.24 | 0.31 | 0.25 | 0.35 | 0.12 |
Renal disease | 0.27 | 0.54 | 0.69 | 0.53 | 0.21 | <0.001 |
Heart attack | 0.53 | 0.69 | 0.75 | 0.68 | 0.52 | 0.01 |
Repeat HDP | 0.87 | 0.90 | 0.94 | 0.90 | 0.71 | <0.001 |
Stroke | 0.47 | 0.62 | 0.81 | 0.63 | 0.53 | 0.14 |
Heart disease | 0.47 | 0.69 | 0.75 | 0.68 | 0.50 | 0.005 |
PVD | 0.33 | 0.50 | 0.50 | 0.32 | 0.45 | <0.001 |
Breast cancer* | 0.20 | 0.52 | 0.31 | 0.47 | 0.65 | 0.004 |
Seizures* | 0.27 | 0.29 | 0.13 | 0.27 | 0.44 | 0.01 |
Overall mean knowledge score (out of 10) | 4.2 | 5.8 | 6.0 | 5.6 | 5.2 | 0.21 |
*Breast cancer and seizures are distractors within the survey. These were included despite being conditions that women after HDP are not at greater risk of.
CH, chronic hypertension worsening in pregnancy and/or with superimposed PE; GH, gestational hypertension; HDP, hypertensive disorders of pregnancy; PE, pre-eclampsia; PVD, peripheral vascular disease.